Cargando…
Lyophilized Drug-Loaded Solid Lipid Nanoparticles Formulated with Beeswax and Theobroma Oil
Solid lipid nanoparticles (SLNs) have the potential to enhance the systemic availability of an active pharmaceutical ingredient (API) or reduce its toxicity through uptake of the SLNs from the gastrointestinal tract or controlled release of the API, respectively. In both aspects, the responses of th...
Autores principales: | Amekyeh, Hilda, Billa, Nashiru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914714/ https://www.ncbi.nlm.nih.gov/pubmed/33572168 http://dx.doi.org/10.3390/molecules26040908 |
Ejemplares similares
-
Practicality of 3D Printed Personalized Medicines in Therapeutics
por: Amekyeh, Hilda, et al.
Publicado: (2021) -
Prospects of Curcumin Nanoformulations in Cancer Management
por: Amekyeh, Hilda, et al.
Publicado: (2022) -
Solid Dispersion Formulations by FDM 3D Printing—A Review
por: Khalid, Garba M., et al.
Publicado: (2022) -
Properties of An Oral Nanoformulation of A Molecularly Dispersed Amphotericin B Comprising A Composite Matrix of Theobroma Oil and Bee’S Wax
por: Tan, Chloe See Wei, et al.
Publicado: (2014) -
Improved Bioavailability of Poorly Soluble Drugs through Gastrointestinal Muco-Adhesion of Lipid Nanoparticles
por: Tan, Sui Ling Janet, et al.
Publicado: (2021)